A latest research report by IMARC group the titled is that “Pneumococcal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a comprehensive analysis of the industry, which comprises insights on pneumococcal vaccine market research report. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global pneumococcal vaccine market grew at a CAGR of around 5% during 2015 to 2020. Looking forward, IMARC Group expects the global pneumococcal vaccine market to exhibit moderate growth during the next five years.
Pneumococcal infections are caused by Streptococcus pneumoniae or pneumococcus bacteria, which can cause severe lung infection (pneumonia), blood infection (bacteremia), and infection in the lining of the brain and spinal cord (meningitis). Children in the age group of 2-5 years and geriatric individuals are the most at-risk population for pneumococcal infections. The pneumococcal vaccine market share stimulates the immune system and prevents the spread of infection, thereby eliminating the need for hospitalization and reducing the fatality rate.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/pneumococcal-vaccine-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
The rising parental concerns towards the high prevalence of pneumococcal infection in infants are propelling the demand for pneumococcal vaccines. Furthermore, the growing geriatric population who are more prone to chronic respiratory diseases is also augmenting the market growth. Additionally, the increasing consumption of cigarettes, snugs, cigars, hookah, etc., has further led to the rising incidences of severe lung diseases, thereby driving the global market. Additionally, the emergence of the Pneumococcal Conjugate Vaccine (PCV) for immunizing infants will continue to bolster the market growth in the coming years.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/pneumococcal-vaccine-market
Competitive Landscape with key players:
The competitive landscape of the industry has also been examined along with the profiles of the key players being.
- Astellas Pharma Inc.
- GlaxoSmithKline Plc.
- Merck & Co. Inc.
- Panacea Biotec Ltd.
- Pfizer Inc.
- Sanofi S.A.
- Serum Institute of India Pvt Ltd
- Walvax Biotechnology Co. Ltd.
Pneumococcal Vaccine Market Segmentation:
Our report has categorized the market based on region, vaccine type, product type, distribution channel and end user.
Market Breakup by Vaccine Type:
- Pneumococcal Conjugate Vaccine
- Pneumococcal Polysaccharide Vaccine
Market Breakup by Product Type:
- Prevnar 13
- Pneumovax 23
Market Breakup by Distribution Channel:
- Distribution Partner Companies
- Non-Governmental Organizations (NGO)
- Government Authorities
Market Breakup by End User:
Market Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800